Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 13, 2021

SELL
$20.53 - $25.22 $9.54 Million - $11.7 Million
-464,694 Closed
0 $0
Q4 2020

Jan 25, 2021

SELL
$18.39 - $24.8 $6.74 Million - $9.09 Million
-366,357 Reduced 44.08%
464,694 $9.33 Million
Q3 2020

Oct 13, 2020

BUY
$20.67 - $26.94 $147,294 - $191,974
7,126 Added 0.86%
831,051 $20.3 Million
Q2 2020

Jul 29, 2020

BUY
$16.46 - $27.42 $302,254 - $503,513
18,363 Added 2.28%
823,925 $19.6 Million
Q1 2020

Apr 21, 2020

SELL
$14.46 - $21.8 $7,967 - $12,011
-551 Reduced 0.07%
805,562 $13.9 Million
Q4 2019

Jan 14, 2020

BUY
$15.15 - $18.89 $68,977 - $86,006
4,553 Added 0.57%
806,113 $14.2 Million
Q3 2019

Oct 29, 2019

SELL
$17.68 - $22.65 $25,176 - $32,253
-1,424 Reduced 0.18%
801,560 $14.2 Million
Q2 2019

Jul 11, 2019

BUY
$18.93 - $24.75 $262,180 - $342,787
13,850 Added 1.76%
802,984 $17.2 Million
Q1 2019

Apr 23, 2019

BUY
$19.6 - $24.76 $921,141 - $1.16 Million
46,997 Added 6.33%
789,134 $18.8 Million
Q4 2018

Feb 11, 2019

SELL
$13.65 - $21.8 $183,524 - $293,101
-13,445 Reduced 1.78%
742,137 $14.6 Million
Q3 2018

Nov 02, 2018

BUY
$15.87 - $22.4 $2.79 Million - $3.93 Million
175,560 Added 30.27%
755,582 $13.4 Million
Q2 2018

Jul 19, 2018

BUY
$18.56 - $22.45 $3.79 Million - $4.59 Million
204,351 Added 54.4%
580,022 $12.5 Million
Q1 2018

May 09, 2018

BUY
$22.15 - $31.89 $8.32 Million - $12 Million
375,671 New
375,671 $8.32 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.6B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Chicago Capital, LLC Portfolio

Follow Chicago Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Capital, LLC with notifications on news.